Greek wearable tech startup, ATRIDE, has recently announced a significant European funding grant from the Interregional Innovation Investments Instrument (I3) and the European Innovation Council & SMEs Executive Agency. The company, based in Athens, has emerged from stealth mode with a 3M euro investment to aid the expansion, validation, and commercialization of their latest innovation in smart clothing.
The ‘Digilung’ shirt, designed for people suffering from chronic respiratory diseases such as COPD and asthma, as well as elite athletes seeking precise physiological performance analytics, utilizes embedded textile and microelectronic sensors to provide personalized care at the point of need. This not only improves patient outcomes but also generates new clinical insights for better disease management.
ATRIDE’s Digilung shirt stands out for its use of proprietary AI/ML algorithms and sensor designs, advanced nanomaterials, and smart garments, all integrated into an elegant t-shirt. The company’s goal is to expand its product portfolio into international markets and usher in a new era of commercial e-textile success.
According to ATRIDE’s founder and Chief Clinical Officer, Maarten Gijssel, the company prioritizes design, ergonomics, and a holistic understanding of modern living, connected lifestyle, and behavioral economics. Gijssel states, “We are a human-first company, using technology as a vehicle to develop extremely desirable and useful products.”
For more information about ATRIDE and their groundbreaking innovations, please visit www.atride.eu or contact info@atride.eu.
ATRIDE, based in Athens, Greece, is a leading product innovator in smart garment design and engineering. Using human-centric design, performance analytics, omnidimensional data-driven solutions, and nanomaterials, the company is committed to transforming the healthcare and wellness landscape.
